% | $
Quotes you view appear here for quick access.

Ariad Pharmaceuticals Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • timothyc121855 timothyc121855 Mar 16, 2012 9:38 AM Flag

    I don't know what to do now

    This is not a huge surprise. Institutional investors are long the stock for ponatinib---where ARIA owns 100% of drug for CML ($ 5 billion opportunity worldwide) where the data suggests that ARIA is best in class. This announcement relates to the product licensed to MRK---where it would have been nice to see positive data but not that big a story & much smaller part of the valuation story. The shorts will make noise on this news but institutional players involved in ARIA will buy up the sellers.

7.97+0.40(+5.28%)Sep 4 4:00 PMEDT